Hiroshi Kijima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroshi Kijima has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Yunyan Wu
Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036‑8562, Japan
3 shared publications- Fuyuki Sato
Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
2 shared publications Hitoshi Yamazaki
2 shared publications- Kenichi Hakamada
Department of Gastroenterological Surgery Hirosaki University Graduate School of Medicine Aomori Japan
2 shared publications - Masato Nakamura
Department of Gastroenterology, Graduate School of Medicine Chiba University Chiba Japan
2 shared publications Satoko Morohashi
Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036‑8562, Japan
2 shared publications
Latest Publications
- 1 May 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (5) , 1167-1176.e3
Autoantibodies to BPAG1e Trigger Experimental Bullous Pemphigoid in Mice
- 1 May 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (5) , 1167-1176.e3
Autoantibodies to BPAG1e Trigger Experimental Bullous Pemphigoid in Mice
- Open Access
- 10 July 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (3) , 3895-3900
Neoangiogenesis of gastric submucosa‑invasive adenocarcinoma
Early gastric cancer may be defined as mucosal or submucosal invasive carcinoma, and exhibits a good prognosis: 90% of patients survive >10 years. Early gastric cancer infrequently exhibits lymph node metastasis, although submucosal invasion, the presence of vascular invasion and/or lymphatic permeation are independent risk factors for lymph node metastasis in early gastric cancer. The analysis of tumor lymphangiogenesis and angiogenesis are important to determine the extent of invasive progression and metastasis in patients. Previously, the presence of vessels expressing the D2‑40 antibody and the factor‑VIII protein has been identified immunohistochemically. The vessels that are immunoreactive for D2‑40 and factor‑VIII are morphologically similar to lymphatic vessels or small‑size veins, also termed venules. In the present study, the association between tumor invasion and neoangiogenesis in early gastric cancer was examined. The D2‑40/factor‑VIII double‑stained vessel (DSV) density was analyzed, in addition to lymphatic and blood vessel (vein and artery) density, using 46 submucosa‑invasive and 50 mucosal carcinomas, and 20 non‑neoplastic gastric tissues. The lymphatic density and DSV density of submucosa beneath the carcinoma and submucosa of the surrounding region in submucosa‑invasive carcinoma were significantly increased (P<0.001) in comparison with those in mucosal carcinoma or non‑neoplastic gastric tissue. No significant difference was observed in blood vessel density between non‑neoplastic gastric, mucosal carcinoma and submucosa‑invasive carcinoma tissues other than that of mucosa. The present study suggests the potential for the presence of D2‑40/factor‑VIII DSV and the importance of this vessel for neoangiogenesis in early gastric cancer.
- 10 July 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (3) , 3895-3900
Open AccessNeoangiogenesis of gastric submucosa‑invasive adenocarcinoma
Early gastric cancer may be defined as mucosal or submucosal invasive carcinoma, and exhibits a good prognosis: 90% of patients survive >10 years. Early gastric cancer infrequently exhibits lymph node metastasis, although submucosal invasion, the presence of vascular invasion and/or lymphatic permeation are independent risk factors for lymph node metastasis in early gastric cancer. The analysis of tumor lymphangiogenesis and angiogenesis are important to determine the extent of invasive progression and metastasis in patients. Previously, the presence of vessels expressing the D2‑40 antibody and the factor‑VIII protein has been identified immunohistochemically. The vessels that are immunoreactive for D2‑40 and factor‑VIII are morphologically similar to lymphatic vessels or small‑size veins, also termed venules. In the present study, the association between tumor invasion and neoangiogenesis in early gastric cancer was examined. The D2‑40/factor‑VIII double‑stained vessel (DSV) density was analyzed, in addition to lymphatic and blood vessel (vein and artery) density, using 46 submucosa‑invasive and 50 mucosal carcinomas, and 20 non‑neoplastic gastric tissues. The lymphatic density and DSV density of submucosa beneath the carcinoma and submucosa of the surrounding region in submucosa‑invasive carcinoma were significantly increased (P<0.001) in comparison with those in mucosal carcinoma or non‑neoplastic gastric tissue. No significant difference was observed in blood vessel density between non‑neoplastic gastric, mucosal carcinoma and submucosa‑invasive carcinoma tissues other than that of mucosa. The present study suggests the potential for the presence of D2‑40/factor‑VIII DSV and the importance of this vessel for neoangiogenesis in early gastric cancer.
- Open Access
- 27 October 2017
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 8 (1) , 54-60
Impact of the histological phenotype of extrahepatic bile duct carcinoma
The classification of histological phenotypes was originally conceived for pancreatic intraductal papillary mucinous neoplasms. Recently, it has been introduced for extrahepatic cholangiocarcinoma. The aim of the present study was to clarify the associations between histological phenotype and clinicopathological features of extrahepatic cholangiocarcinoma, using 99 cases of surgically‑resected extrahepatic cholangiocarcinoma. All cases were divided into one of two histological phenotypes: Biliary‑type (BT; 56 cases, 56.6%) or metaplastic‑type (MT; 43 cases, 43.4%). The clinicopathological features were compared between these two phenotypes. BT tumors exhibited significantly poorer differentiation, more frequent lymph node metastasis (BT vs. MT, 42.9 vs. 30.2%; P=0.042), more severe venous invasion (v2‑3: BT vs. MT, 64.3 vs. 23.3%; P<0.001), and more severe perineural invasion (ne2‑3: BT vs. MT, 78.6 vs. 48.8%, P=0.002). Furthermore, the overall (P=0.015) and disease‑free (P=0.003) survival times were significantly decreased in patients with BT vs. MT tumors. In conclusion, extrahepatic cholangiocarcinoma with a BT phenotype has greater malignant potential, and may be an important predictive factor for poor prognosis.
- 27 October 2017
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 8 (1) , 54-60
Open AccessImpact of the histological phenotype of extrahepatic bile duct carcinoma
The classification of histological phenotypes was originally conceived for pancreatic intraductal papillary mucinous neoplasms. Recently, it has been introduced for extrahepatic cholangiocarcinoma. The aim of the present study was to clarify the associations between histological phenotype and clinicopathological features of extrahepatic cholangiocarcinoma, using 99 cases of surgically‑resected extrahepatic cholangiocarcinoma. All cases were divided into one of two histological phenotypes: Biliary‑type (BT; 56 cases, 56.6%) or metaplastic‑type (MT; 43 cases, 43.4%). The clinicopathological features were compared between these two phenotypes. BT tumors exhibited significantly poorer differentiation, more frequent lymph node metastasis (BT vs. MT, 42.9 vs. 30.2%; P=0.042), more severe venous invasion (v2‑3: BT vs. MT, 64.3 vs. 23.3%; P<0.001), and more severe perineural invasion (ne2‑3: BT vs. MT, 78.6 vs. 48.8%, P=0.002). Furthermore, the overall (P=0.015) and disease‑free (P=0.003) survival times were significantly decreased in patients with BT vs. MT tumors. In conclusion, extrahepatic cholangiocarcinoma with a BT phenotype has greater malignant potential, and may be an important predictive factor for poor prognosis.
- 1 July 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47 (11) , 1747-1758
PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells
- 1 July 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47 (11) , 1747-1758
PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells
- Open Access
- 1 January 2009
- Published by Biomedical Research Press in Biomedical Research
- Vol. 30 (2) , 79-86
Expression of syndecan-1 and E-cadherin is inversely correlated with poor patient's prognosis and recurrent status of extrahepatic bile duct carcinoma
Extrahepatic bile duct carcinoma is one of the most extremely aggressive cancers with poor prognosis after curative resection. Syndecan-1 and E-cadherin are transmembrane glycoproteins, and have important roles in cell-cell adhesion and tumor progression. In this study, we examined 84 surgically resected cases of extrahepatic bile duct adenocarcinoma to clarify clinicopathological significance of syndecan-1/E-cadherin expression. Reduced expressions of syndecan-1 and Ecadherin were found in 69.0% (58/84) and 46.4% (39/84) of the bile duct carcinomas. Reduced syndecan-1 expression was correlated with lymphatic/venous/nervous invasion (P < 0.0001), and was associated with short overall survival (P = 0.0002). Reduced E-cadherin expression was correlated with lymphatic and nervous invasion (P = 0.008, P < 0.0001, respectively), and was associated with short overall survival (P = 0.0038). The results indicated that reduced syndecan-1/E-cadherin expression may be good indicators of recurrence and prognosis in extrahepatic bile duct carcinoma.
- 1 January 2009
- Published by Biomedical Research Press in Biomedical Research
- Vol. 30 (2) , 79-86
Open AccessExpression of syndecan-1 and E-cadherin is inversely correlated with poor patient's prognosis and recurrent status of extrahepatic bile duct carcinoma
Extrahepatic bile duct carcinoma is one of the most extremely aggressive cancers with poor prognosis after curative resection. Syndecan-1 and E-cadherin are transmembrane glycoproteins, and have important roles in cell-cell adhesion and tumor progression. In this study, we examined 84 surgically resected cases of extrahepatic bile duct adenocarcinoma to clarify clinicopathological significance of syndecan-1/E-cadherin expression. Reduced expressions of syndecan-1 and Ecadherin were found in 69.0% (58/84) and 46.4% (39/84) of the bile duct carcinomas. Reduced syndecan-1 expression was correlated with lymphatic/venous/nervous invasion (P < 0.0001), and was associated with short overall survival (P = 0.0002). Reduced E-cadherin expression was correlated with lymphatic and nervous invasion (P = 0.008, P < 0.0001, respectively), and was associated with short overall survival (P = 0.0038). The results indicated that reduced syndecan-1/E-cadherin expression may be good indicators of recurrence and prognosis in extrahepatic bile duct carcinoma.
- Open Access
- 1 January 2007
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 212 (2) , 143-150
Colonization and Differentiation of Transplanted Embryonic Stem Cells in the Irradiated Intestine of Mice
Radiation-induced intestinal injury is a common complication in radiotherapy for the cancer located in abdomen or pelvis. However, there is no effective treatment for radiation-induced intestinal injury now. It is therefore important to develop new treatments for radiation-induced intestinal injury. In this study, we investigated whether embryonic stem (ES) cells could be transplanted directly into the radiation-damaged intestine and could colonize and differentiate into the intestinal epithelial cells. The intestines of female nude mice (ICR nu/nu) were irradiated at a single dose of 30 Gy, and were immediately transplanted with male 129/Sv-derived ES cells into the wall of the irradiated intestine by direct injection. The intestine was removed on days 13 to 27 after transplantation. The Y-chromosome DNA of transplanted ES cells in the irradiated intestine was determined by polymerase chain reaction. Colonization and differentiation of transplanted ES cells in the irradiated intestine were analyzed by histological and immunohistochemical methods with antibodies against stage-specific embryonic antigen-1, α-smooth muscle actin and cytokeratin AE1/AE3. The cells of donor origin were identified in the intestine of irradiated mice, and intestinal crypt-like structures were observed on day 13 after transplantation. Importantly, we observed that ES cells could differentiate into epithelial cells in the submucosa of irradiated intestine on day 13 and 27 after transplantation. These results suggest that transplanted ES cells could colonize and differentiate in the intestinal intestine. Such a new approach for damaged intestine with transplanted stem cells would be promising.
- 1 January 2007
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 212 (2) , 143-150
Open AccessColonization and Differentiation of Transplanted Embryonic Stem Cells in the Irradiated Intestine of Mice
Radiation-induced intestinal injury is a common complication in radiotherapy for the cancer located in abdomen or pelvis. However, there is no effective treatment for radiation-induced intestinal injury now. It is therefore important to develop new treatments for radiation-induced intestinal injury. In this study, we investigated whether embryonic stem (ES) cells could be transplanted directly into the radiation-damaged intestine and could colonize and differentiate into the intestinal epithelial cells. The intestines of female nude mice (ICR nu/nu) were irradiated at a single dose of 30 Gy, and were immediately transplanted with male 129/Sv-derived ES cells into the wall of the irradiated intestine by direct injection. The intestine was removed on days 13 to 27 after transplantation. The Y-chromosome DNA of transplanted ES cells in the irradiated intestine was determined by polymerase chain reaction. Colonization and differentiation of transplanted ES cells in the irradiated intestine were analyzed by histological and immunohistochemical methods with antibodies against stage-specific embryonic antigen-1, α-smooth muscle actin and cytokeratin AE1/AE3. The cells of donor origin were identified in the intestine of irradiated mice, and intestinal crypt-like structures were observed on day 13 after transplantation. Importantly, we observed that ES cells could differentiate into epithelial cells in the submucosa of irradiated intestine on day 13 and 27 after transplantation. These results suggest that transplanted ES cells could colonize and differentiate in the intestinal intestine. Such a new approach for damaged intestine with transplanted stem cells would be promising.
- 1 September 2006
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 291 (3) , R651-R656
Nitric oxide modulates elicitation of reflex swallowing from the pharynx in rats
The pharynx is very important for elicitation of reflex swallowing. The region of the pharynx is innervated by the pharyngeal branch of the glossopharyngeal nerve (GPN-ph). Nitric oxide (NO) plays an important role in various physiological functions. The purpose of this study is to investigate the contribution of NO to reflex swallowing evoked by electrical stimulation of the GPN-ph. Swallowing was evoked in urethane-anesthetized rats by application of repetitive electrical stimulation (10- to 20-μA amplitude, 10- to 20-Hz frequency, 1.0-ms duration) to the central cut end of the GPN-ph or superior laryngeal nerve. Swallowing was identified by electromyographic activity of the mylohyoid muscle. Latency to the first swallow and the interval between swallows were measured. Intravenous administration of NG-nitro-l-arginine (l-NNA, 0.6 mg/kg), a nonselective inhibitor of NO synthase (NOS), extremely prolonged latency to the first swallow and the interval between swallows evoked by the GPN-ph. Intraperitoneal administration of 7-nitroindazole (5.0 mg/kg), a selective inhibitor of neuronal NOS, significantly prolonged latency to the first swallow and the interval between swallows evoked by the GPN-ph. Administration of l-arginine (an NO donor, 500 mg/kg) and sodium nitroprusside (an NO releaser, 0.6 mg/kg) restored the suppression of swallowing induced by the NOS inhibitor. Superior laryngeal nerve-evoked swallowing was suppressed by administration of a higher dose of l-NNA (6.0 mg/kg). Swallowing evoked by water stimulation of the pharynx was also suppressed by l-NNA (0.6 mg/kg). These results suggest that NO plays an important role in signal processing for initiation of reflex swallowing from the pharynx.
- 1 September 2006
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 291 (3) , R651-R656
Nitric oxide modulates elicitation of reflex swallowing from the pharynx in rats
The pharynx is very important for elicitation of reflex swallowing. The region of the pharynx is innervated by the pharyngeal branch of the glossopharyngeal nerve (GPN-ph). Nitric oxide (NO) plays an important role in various physiological functions. The purpose of this study is to investigate the contribution of NO to reflex swallowing evoked by electrical stimulation of the GPN-ph. Swallowing was evoked in urethane-anesthetized rats by application of repetitive electrical stimulation (10- to 20-μA amplitude, 10- to 20-Hz frequency, 1.0-ms duration) to the central cut end of the GPN-ph or superior laryngeal nerve. Swallowing was identified by electromyographic activity of the mylohyoid muscle. Latency to the first swallow and the interval between swallows were measured. Intravenous administration of NG-nitro-l-arginine (l-NNA, 0.6 mg/kg), a nonselective inhibitor of NO synthase (NOS), extremely prolonged latency to the first swallow and the interval between swallows evoked by the GPN-ph. Intraperitoneal administration of 7-nitroindazole (5.0 mg/kg), a selective inhibitor of neuronal NOS, significantly prolonged latency to the first swallow and the interval between swallows evoked by the GPN-ph. Administration of l-arginine (an NO donor, 500 mg/kg) and sodium nitroprusside (an NO releaser, 0.6 mg/kg) restored the suppression of swallowing induced by the NOS inhibitor. Superior laryngeal nerve-evoked swallowing was suppressed by administration of a higher dose of l-NNA (6.0 mg/kg). Swallowing evoked by water stimulation of the pharynx was also suppressed by l-NNA (0.6 mg/kg). These results suggest that NO plays an important role in signal processing for initiation of reflex swallowing from the pharynx.
- 1 March 2003
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 11 (3) , 305-309
Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis
Pancreatic cancer is a malignant tumor with an extremely poor prognosis. The mechanisms of the aggressive growth and metastasis are not yet extensively understood. Over-expression of epidermal growth factor receptor (EGFR) was suggested to be associated with malignant transformation of pancreatic cancer. We examined EGFR expression in 77 cases of invasive ductal adenocarcinoma of the pancreas, and analyzed the relation between the EGFR expression pattern and clinicopathological factors. EGFR immunoreactivity was detected in 41.6% (32/77) of human pancreatic cancers; i.e. diffuse expression in 32.5% (25/77) and focal expression in 9.1% (7/77). The EGFR expression was associated with gender (p<0.05), histological differentiation (p<0.05) and metastatic status of TNM classification (p<0.01). The observations suggested that EGFR expression plays important roles in metastasis, especially liver metastasis and recurrence of human pancreatic cancer.
- 1 March 2003
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 11 (3) , 305-309
Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis
Pancreatic cancer is a malignant tumor with an extremely poor prognosis. The mechanisms of the aggressive growth and metastasis are not yet extensively understood. Over-expression of epidermal growth factor receptor (EGFR) was suggested to be associated with malignant transformation of pancreatic cancer. We examined EGFR expression in 77 cases of invasive ductal adenocarcinoma of the pancreas, and analyzed the relation between the EGFR expression pattern and clinicopathological factors. EGFR immunoreactivity was detected in 41.6% (32/77) of human pancreatic cancers; i.e. diffuse expression in 32.5% (25/77) and focal expression in 9.1% (7/77). The EGFR expression was associated with gender (p<0.05), histological differentiation (p<0.05) and metastatic status of TNM classification (p<0.01). The observations suggested that EGFR expression plays important roles in metastasis, especially liver metastasis and recurrence of human pancreatic cancer.
- Open Access
- 1 January 2003
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 64 (5) , 1090-1093
A CASE OF PANCREATIC METASTASIS FROM LUNG CANCER
- 1 January 2003
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 64 (5) , 1090-1093
Open AccessA CASE OF PANCREATIC METASTASIS FROM LUNG CANCER
Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo
We established a xenograft line of human adrenocortical carcinoma (ADR‐1), and analyzed the hyper‐aldosteronism induced by the xenograft in vivo. Adrenocortical carcinoma specimens from a 25‐year‐old woman were subcutaneously inoculated into nude mice (BALB/c‐nu/nu) followed by serial passages in vivo. ADR‐1 retained the histopathological features (trabecular and sinusoid nests) seen in the primary carcinoma. The patient showed hyperaldosteronism (serum aldosterone >4000 pg/ml) and hypokalemia (serum K 2.1 mEq/1), but did not show hypertension. The nude rat (F344‐rnu/rnu) bearing ADR‐1 showed hyperaldosteronism (serum aldosterone 3320 ± 1420 pg/ml; control 191 ± 130 pg/ml) and hypokalemia (serum K 3.4 ± 0.4 mEq/1; control 5.2 ± 1.0 mEq/1) in vivo, and hypertension was not obvious. ADR‐1 was shown immunohistochemically to retain production of human‐specific corticosteroid synthetase. The xenograft ADR‐1 will be useful to elucidate the regulatory mechanism of normotensive hyperaldosteronism.
Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo
We established a xenograft line of human adrenocortical carcinoma (ADR‐1), and analyzed the hyper‐aldosteronism induced by the xenograft in vivo. Adrenocortical carcinoma specimens from a 25‐year‐old woman were subcutaneously inoculated into nude mice (BALB/c‐nu/nu) followed by serial passages in vivo. ADR‐1 retained the histopathological features (trabecular and sinusoid nests) seen in the primary carcinoma. The patient showed hyperaldosteronism (serum aldosterone >4000 pg/ml) and hypokalemia (serum K 2.1 mEq/1), but did not show hypertension. The nude rat (F344‐rnu/rnu) bearing ADR‐1 showed hyperaldosteronism (serum aldosterone 3320 ± 1420 pg/ml; control 191 ± 130 pg/ml) and hypokalemia (serum K 3.4 ± 0.4 mEq/1; control 5.2 ± 1.0 mEq/1) in vivo, and hypertension was not obvious. ADR‐1 was shown immunohistochemically to retain production of human‐specific corticosteroid synthetase. The xenograft ADR‐1 will be useful to elucidate the regulatory mechanism of normotensive hyperaldosteronism.